No. (%) of patients†
|
110 (21)
|
124 (21)
|
117 (11)
|
351 (16)
|
NA
|
Women
|
81 (74)
|
93 (75)
|
98 (84)
|
272 (77)
|
0.13
|
NA
|
Men
|
29 (26)
|
31 (25)
|
19 (16)
|
79 (23)
|
Age, mean (SD), y
|
64 (9.56)
|
64 (10.40)
|
64 (10.55)
|
64 (10.2)
|
0.88
|
<0.001
|
Age range, y
|
50-87
|
50-90
|
50-89
|
50-90
|
NA
|
Time to complete RAQ, mean (SD), min
|
3.26 (1.05)
|
3.42 (1.29)
|
3.60 (1.28)
|
3.43
|
0.08
|
0.37
|
Range of completion time, mean, min
|
1.32-7.93
|
1.37-8.01
|
1.37-7.38
|
1.32-8.01
|
NA
|
Number of visits, mean (SD)
|
3.29 (1.95)
|
2.37 (1.85)
|
3.25 (3.14)
|
2.95 (2.4)
|
0.004
|
0.88
|
Range†
|
0-10
|
0-9
|
0-25
|
0-25
|
NA
|
Number (%) of patients who had a BMD test
|
Over 2 y ago
|
39 (35)
|
38 (31)
|
24 (21)
|
101 (29)
|
0.03
|
<0.001
|
Less than 2 y ago
|
38 (35)
|
30 (24)
|
35 (30)
|
103 (29)
|
0.22
|
0.005
|
Never
|
33 (30)
|
56 (45)
|
58 (50)
|
147 (42)
|
0.008
|
<0.001
|
Number (%) of patients at risk for osteoporosis†
|
88 (80)
|
97 (78)
|
91 (78)
|
276 (79)
|
0.91
|
<0.001
|
Number (%) of patients already receiving therapy
|
Osteoporosis medications
|
8 (7)
|
13 (10)
|
11 (9)
|
32 (9)
|
0.69
|
0.02
|
Any supplement (calcium or vitamin D)
|
71 (65)
|
81 (65)
|
81 (69)
|
233 (66)
|
0.72
|
<0.001
|